Nocturne
Berlin
About Nocturne
Nocturne diagnoses neurological disorders with retinal image analysis. Nocturne’s proprietary technology (patent pending) analyses 3D images of the retina, which are obtained by optical coherence tomography (OCT). OCT is a noninvasive imaging technology routinely used in ophthalmology. Standard OCT devices are affordable but are by themselves of only limited value for neurologic applications. Nocturne was founded in Berlin, Germany, in February 2018. The founding team comprises one medical image analysis expert, one mathematical modelling expert, one clinical neuroscientist and neurodiagnostics expert and one leading neurologist as scientific advisor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $81.9K
- Funding stage: Seed
- Last round: Grant (Jan 2019)
- Website: nocturne.one
- Phone: 49157580444
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Software
Social Profiles
Canonical: https://fsome.com/organization/nocturne-153494 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.